180 related articles for article (PubMed ID: 8835746)
21. Intrahepatic cholangiocarcinoma: new insights in pathology.
Sempoux C; Jibara G; Ward SC; Fan C; Qin L; Roayaie S; Fiel MI; Schwartz M; Thung SN
Semin Liver Dis; 2011 Feb; 31(1):49-60. PubMed ID: 21344350
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathologic study of mixed adenoneuroendocrine carcinomas of hepatobiliary organs.
Harada K; Sato Y; Ikeda H; Maylee H; Igarashi S; Okamura A; Masuda S; Nakanuma Y
Virchows Arch; 2012 Mar; 460(3):281-9. PubMed ID: 22358181
[TBL] [Abstract][Full Text] [Related]
23. A combined hepatocellular/cholangiocellular carcinoma with sarcomatoid features.
Papotti M; Sambataro D; Marchesa P; Negro F
Liver; 1997 Feb; 17(1):47-52. PubMed ID: 9062880
[TBL] [Abstract][Full Text] [Related]
24. Immunostaining for polycomb group protein EZH2 and senescent marker p16INK4a may be useful to differentiate cholangiolocellular carcinoma from ductular reaction and bile duct adenoma.
Sasaki M; Matsubara T; Kakuda Y; Sato Y; Nakanuma Y
Am J Surg Pathol; 2014 Mar; 38(3):364-9. PubMed ID: 24487593
[TBL] [Abstract][Full Text] [Related]
25. Expression of Ep-CAM in normal, regenerating, metaplastic, and neoplastic liver.
de Boer CJ; van Krieken JH; Janssen-van Rhijn CM; Litvinov SV
J Pathol; 1999 Jun; 188(2):201-6. PubMed ID: 10398165
[TBL] [Abstract][Full Text] [Related]
26. Alpha-smooth muscle actin-positive fibroblasts promote biliary cell proliferation and correlate with poor survival in cholangiocarcinoma.
Chuaysri C; Thuwajit P; Paupairoj A; Chau-In S; Suthiphongchai T; Thuwajit C
Oncol Rep; 2009 Apr; 21(4):957-69. PubMed ID: 19287994
[TBL] [Abstract][Full Text] [Related]
27. Expression of alpha-smooth muscle actin in liver diseases.
Yu E; Choe G; Gong G; Lee I
J Korean Med Sci; 1993 Oct; 8(5):367-73. PubMed ID: 8305144
[TBL] [Abstract][Full Text] [Related]
28. SPARC expression in desmoplastic and non desmoplastic pancreatic carcinoma and cholangiocarcinoma.
Khetan K; Baloda V; Sahoo RK; Vishnubhathla S; Yadav R; Saraya A; Sharma A; Gupta SD; Das P
Pathol Res Pract; 2019 Dec; 215(12):152685. PubMed ID: 31727501
[TBL] [Abstract][Full Text] [Related]
29. Histopathology of hepatocellular carcinoma.
Schlageter M; Terracciano LM; D'Angelo S; Sorrentino P
World J Gastroenterol; 2014 Nov; 20(43):15955-64. PubMed ID: 25473149
[TBL] [Abstract][Full Text] [Related]
30. CD34-positive stromal cells and alpha-smooth muscle actin-positive stromal cells in the tumor capsule of skin sweat gland neoplasms.
Nakayama H; Enzan H; Miyazaki E; Moriki T; Toi M; Zhang Y
Pathol Int; 2002 Jan; 52(1):25-30. PubMed ID: 11940203
[TBL] [Abstract][Full Text] [Related]
31. Primary intrahepatic small-cell carcinoma arising from combined hepatocellular and cholangiocarcinomas.
Khaw YL; Nolan N; Heaslip I; McCormick PA; Sheahan K
J Clin Oncol; 2011 Jul; 29(21):e630-3. PubMed ID: 21606429
[No Abstract] [Full Text] [Related]
32. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
[TBL] [Abstract][Full Text] [Related]
33. Alternative lengthening of telomeres in primary hepatic neoplasms.
Yasir S; Thompson S; Chen ZE; Knudson R; Knutson D; Kloft-Nelson S; Graham RP; Jain D; Simon SM; Wu TT; Torbenson M
Hum Pathol; 2023 Jan; 131():79-86. PubMed ID: 36370823
[TBL] [Abstract][Full Text] [Related]
34. The utility of keratin 903 as a new prognostic marker in mass-forming-type intrahepatic cholangiocarcinoma.
Aishima S; Asayama Y; Taguchi K; Sugimachi K; Shirabe K; Shimada M; Sugimachi K; Tsuneyoshi M
Mod Pathol; 2002 Nov; 15(11):1181-90. PubMed ID: 12429797
[TBL] [Abstract][Full Text] [Related]
35. The disappearance of CD34-positive and alpha-smooth muscle actin-positive stromal cells associated with human intra-uterine and tubal pregnancies.
Kuroda N; Miyazaki E; Hayashi Y; Toi M; Hiroi M; Enzan H
Histol Histopathol; 2004 Jul; 19(3):707-13. PubMed ID: 15168331
[TBL] [Abstract][Full Text] [Related]
36. Elevated expression of Bmi1 in hepatocellular carcinoma with bile duct tumor thrombi.
Zhang R; Xu LB; Zeng H; Yu XH; Wang J; Liu C
Hepatogastroenterology; 2013; 60(128):2042-7. PubMed ID: 24719948
[TBL] [Abstract][Full Text] [Related]
37. Nucleolar organizer regions in cirrhosis and hepatocellular carcinoma.
Jain R; Malhotra V; Kumar N; Sarin SK
Trop Gastroenterol; 1998; 19(3):100-1. PubMed ID: 9828706
[TBL] [Abstract][Full Text] [Related]
38. Cytologic features of fibrolamellar carcinoma with mucin production: a rare variant of combined hepatocellular-cholangiocarcinoma.
Rosa M; Mohammadi A
Diagn Cytopathol; 2014 May; 42(5):431-5. PubMed ID: 23008149
[TBL] [Abstract][Full Text] [Related]
39. Sarcomatous cholangiocarcinoma.
Gupta K; Powari M; Dey P
Diagn Cytopathol; 2003 Mar; 28(3):168-9. PubMed ID: 12619101
[No Abstract] [Full Text] [Related]
40. Topographical immunohistochemical expression of bcl-2 protein in human liver lesions.
Skopelitou A; Hadjiyannakis M; Alexopoulou V; Krikoni O; Kamina S; Agnantis N
Anticancer Res; 1996; 16(2):975-8. PubMed ID: 8687162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
